Exciting News in Research for Age-Related Macular Degeneration

Jan 8, 2018

Credit UA Ophthalmology - University of Arizona

There's an AMD Trial that is showing great promise for people dealing with vision loss from Age-Related Macular Degeneration (AMD).  Brian S. McKay, PhD, Director of Basic Research, SW Center for Age-Related Eye Diseases, at the University of Arizona is studying Levodopa (L-dopa), a drug used to treat Parkinson's disease, restless leg syndrome and other movement disorders.  And thanks to a $1.7 million grant from the National Eye Institute of the National Institutes of Health, Dr. McKay is ready to take his research study to the next level.

There's much more to learn about this research and the possibilities. 

Preventing Age-Related Macular Degeneration...finally.

Quest to End Macular Degeneration Continues With $1.7M Grant